News & Analysis as of

Regulatory Agenda › Antitrust Provisions › Investment

Skadden, Arps, Slate, Meagher & Flom LLP

Merger Control in a Changing Global Context: Four Key Themes for Dealmakers

Skadden, Arps, Slate, Meagher & Flom LLP on

- What is new: Merger control is becoming increasingly more complex as policy and geopolitical priorities shift across the globe. - Why it matters: These developments increase the unpredictability of multijurisdictional...more

Skadden, Arps, Slate, Meagher & Flom LLP

M&A in the AI Era: Key Antitrust and National Security Considerations

Skadden, Arps, Slate, Meagher & Flom LLP on

Key Points - - As more jurisdictions adopt AI regulations, and AI-related transactions are reviewed on multiple legal grounds, it is critical for companies considering deals to assess the regulatory hurdles early on and...more

White & Case LLP

The CMA’s “revised” approach to UK merger control and impact on M&A

White & Case LLP on

The UK’s Competition & Markets Authority (CMA) is taking significant steps to evolve its approach to merger control, introducing a new Mergers Charter and launching a review of its merger remedies framework. These initiatives...more

Mayer Brown

Europe Daily News 26 February 2025

Mayer Brown on

COMPETITION - Prior notification of a concentration (Case M.11872 - Triton / Keenfinity) - Commission clears creation of a joint venture by PSS and Maccaferri (M.11862) - Midday Express...more

Baker Botts L.L.P.

New Strategic Steer for the CMA Aims to Foster Innovation and International Investment

Baker Botts L.L.P. on

A new strategic steer[1] published by the UK Government for consultation on 13th February 2025 seeks to change the CMA’s direction, focusing on growth and promoting investment in the UK via a series of measures aimed at...more

Skadden, Arps, Slate, Meagher & Flom LLP

2025 Insights: A First Look at Trump’s Second Term

Skadden, Arps, Slate, Meagher & Flom LLP on

As we step into a new year, the potential shifts under a second Trump administration loom large. Our 2025 Insights publication analyzes the impacts these changes could have on both U.S. and global business environments,...more

DLA Piper

Supporting the Health of your Healthcare Organization

DLA Piper on

Private equity sponsors and their healthcare portfolio companies are expected to ride the tailwind of an M&A rebound. Long-term capital gains tax rates will likely remain unchanged, or possibly drop. As a result, sellers may...more

A&O Shearman

Antitrust in focus March 2024

A&O Shearman on

This newsletter is a summary of the antitrust developments we think are most interesting to your business. Thomas Masterman, partner based in London, is our editor this month. He has selected: Out now: our latest global...more

8 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide